Neoplasms Benign Malignant And Unspecified Incl Cysts And Polyps clinical trials

Explore recruiting neoplasms benign malignant and unspecified incl cysts and polyps clinical trials.

Recruiting neoplasms benign malignant and unspecified incl cysts and polyps studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Neoplasms Benign Malignant And Unspecified Incl Cysts And Polyps trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A 2-part phase 1/2 open-label trial evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of ODM-212 in combination with anti-cancer therapy in participants with advanced solid tumours

Finland, Denmark, Spain, France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A phase 1/2, first-in-human study on ODM-212 in subjects with selected advanced solid tumours

Spain, Finland, France

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

LOXO-RAS-20001; A Phase 1a/1b Study of LY3537982 in Patients with KRAS G12C-Mutant Advanced Solid Tumors

France

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Phase II, Multicenter, Open-label Study to Evaluate the Efficacy and Safety of Trastuzumab Deruxtecan (T-DXd) for the Treatment of Unresectable and/or Metastatic Solid Tumors Harboring HER2 Activating Mutations Regardless of Tumor Histology

Denmark, France

Therapeutic exploratory (Phase II) EU CTIS Study details

SARCOME 09_Intergroup Study (SFCE/GSF-GETO) OS2006 - Zoledronate Osteosarcoma Treatment Protocol for osteosarcoma of the child, adolescent and adult including: - A randomized trial - And biological studies.

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Single center, Open-Label, Randomized Study to Evaluate the Safety and Efficacy of neoadjuvant and adjuvant Pembrolizumab on top of standard Chemo-Radiotherapy (Stupp protocol) in Treatment of Patients with newly diagnosed Glioblastoma Multiforme (GBM). (PIRG)

Poland

Therapeutic use (Phase IV) EU CTIS Study details

Neoplasms Benign Malignant And Unspecified Incl Cysts And Polyps trials by city

Neoplasms Benign Malignant And Unspecified Incl Cysts And Polyps clinical trials

Recruiting neoplasms benign malignant and unspecified incl cysts and polyps studies right now

A Study Comparing the Necessity of a Second Transurethral Resection in High-Risk Non-Muscle-Invasive Bladder Cancer Patients With Negative Results From Post-Initial Resection Urine Genome-Wide Low-Depth Sequencing

GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults

Use of a New Medicine "Daratumumab" to Treat Left-over Cancer in a Blood Cancer Called "T Acute Lymphoblastic Leukemia"

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

A Multi-Arm, Platform Trial For Relapsed Neuroblastoma

Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor

Lenvatinib Plus Sintilimab in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Liver Cancer

Tislelizumab Combined With Chemotherapy Followed by Surgery Versus Up-front Surgery in Resectable Head and Neck Squamous Cell Carcinoma (REDUCTION-I)

LCAR-F33S in Treatment of Relapsed/Refractory Multiple Myeloma

Intravital Microscopy in Human Solid Tumors

Nimotuzumab Combined With Immunotherapy and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

Automated Cervical Cancer Screening Using a Smartphone-based Artificial Intelligence Classifier